Literature DB >> 11867196

Serum retinol and risk of hepatocellular carcinoma in patients with child-Pugh class A cirrhosis.

Caterina Clemente1, Silvana Elba, Gianpiero Buongiorno, Pasquale Berloco, Vito Guerra, Alfredo Di Leo.   

Abstract

Liver cirrhosis is the main risk factor for the development of human hepatocellular carcinoma (HCC). In this condition, the liver and plasma suffer a drastic depletion of retinoids. This study was conducted to investigate whether any relation exists between serum retinol levels and HCC development in cirrhotics. Seventy child-Pugh class A cirrhotic patients, 16 child-Pugh class A cirrhotic patients with HCC, and 140 age- and sex-matched subjects were included in this study. At the time of enrollment, fasting blood samples were taken to determine serum retinol levels. For the following 7 years, the 70 cirrhotic patients were also followed up for the occurrence of HCC by periodic screening with ultrasonography and serum alpha-fetoprotein assays. The serum retinol levels in both cirrhotic patients and HCC patients were significantly lower than those in healthy subjects. Among the 70 cirrhotic patients, 14 HCC were detected during follow-up. The prediagnostic retinol levels were significantly lower in cirrhotic patients who developed HCC compared with patients who did not. The odds ratio of cirrhotic patients who developed HCC in the lowest tertile to highest tertile of retinol status was 6.75 (95% CI=1.26--36.0; P=0.015). Our results suggest that a state of retinoid deficiency may promote hepatocarcinogenesis in patients at high risk such as cirrhotics.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11867196     DOI: 10.1016/s0304-3835(01)00843-6

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  14 in total

Review 1.  Role of vitamins in gastrointestinal diseases.

Authors:  Omar A Masri; Jean M Chalhoub; Ala I Sharara
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

Review 2.  Hepatic metabolism of retinoids and disease associations.

Authors:  Yohei Shirakami; Seung-Ah Lee; Robin D Clugston; William S Blaner
Journal:  Biochim Biophys Acta       Date:  2011-07-01

3.  Decreased expression of type II tumor suppressor gene RARRES3 in tissues of hepatocellular carcinoma and cholangiocarcinoma.

Authors:  Shun-Yuan Jiang; Jung-Mao Chou; Fur-Jiang Leu; Yu-Yen Hsu; Yu-Lung Shih; Jyh-Cherng Yu; Meei-Shyuan Lee; Rong-Yaun Shyu
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

4.  Association between liver vitamin A reserves and severity of nonalcoholic fatty liver disease in the class III obese following bariatric surgery.

Authors:  Gabriela Villaça Chaves; Sílvia Elaine Pereira; Carlos José Saboya; Daiane Spitz; Camila Santos Rodrigues; Andréa Ramalho
Journal:  Obes Surg       Date:  2014-02       Impact factor: 4.129

5.  Acyclic retinoid in chemoprevention of hepatocellular carcinoma: Targeting phosphorylated retinoid X receptor-α for prevention of liver carcinogenesis.

Authors:  Masahito Shimizu; Yohei Shirakami; Kenji Imai; Koji Takai; Hisataka Moriwaki
Journal:  J Carcinog       Date:  2012-08-30

6.  Association of serum α-tocopherol, β-carotene, and retinol with liver cancer incidence and chronic liver disease mortality.

Authors:  G Y Lai; S J Weinstein; D Albanes; P R Taylor; J Virtamo; K A McGlynn; N D Freedman
Journal:  Br J Cancer       Date:  2014-10-14       Impact factor: 7.640

7.  Effects of α-tocopherol and β-carotene supplementation on liver cancer incidence and chronic liver disease mortality in the ATBC study.

Authors:  G Y Lai; S J Weinstein; P R Taylor; K A McGlynn; J Virtamo; M H Gail; D Albanes; N D Freedman
Journal:  Br J Cancer       Date:  2014-10-14       Impact factor: 7.640

8.  Retinoid and carotenoid status in serum and liver among patients at high-risk for liver cancer.

Authors:  Yachana Kataria; Ryan J Deaton; Erika Enk; Ming Jin; Milita Petrauskaite; Linlin Dong; Joseph R Goldenberg; Scott J Cotler; Donald M Jensen; Richard B van Breemen; Peter H Gann
Journal:  BMC Gastroenterol       Date:  2016-02-29       Impact factor: 3.067

9.  Retinol supplements antiviral action of interferon in patients with chronic hepatitis C: a prospective pilot study.

Authors:  Naruaki Kohge; Shuichi Sato; Sachiko Hamamoto; Shuji Akagi; Yasushi Uchida; Tatsuya Miyake; Tomoko Mishiro; Kohichiro Furuta; Naoki Oshima; Junnichi Ishine; Yoshiko Takahashi; Norihisa Ishimura; Ryo Fukuda; Shunji Ishihara; Yuji Amano; Yoshikazu Kinoshita
Journal:  J Clin Biochem Nutr       Date:  2009-12-29       Impact factor: 3.114

10.  Genome-wide transcriptional reorganization associated with senescence-to-immortality switch during human hepatocellular carcinogenesis.

Authors:  Gokhan Yildiz; Ayca Arslan-Ergul; Sevgi Bagislar; Ozlen Konu; Haluk Yuzugullu; Ozge Gursoy-Yuzugullu; Nuri Ozturk; Cigdem Ozen; Hilal Ozdag; Esra Erdal; Sedat Karademir; Ozgul Sagol; Dilsa Mizrak; Hakan Bozkaya; Hakki Gokhan Ilk; Ozlem Ilk; Biter Bilen; Rengul Cetin-Atalay; Nejat Akar; Mehmet Ozturk
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.